582 related articles for article (PubMed ID: 16896316)
1. Proteomic analysis of inclusion body myositis.
Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
[TBL] [Abstract][Full Text] [Related]
2. Two-dimensional gel electrophoresis in inclusion body myositis.
Hutchinson DO; Jongbloed B
J Clin Neurosci; 2008 Apr; 15(4):440-4. PubMed ID: 18258434
[TBL] [Abstract][Full Text] [Related]
3. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
[TBL] [Abstract][Full Text] [Related]
4. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
5. Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis.
Broccolini A; Gidaro T; Morosetti R; Gliubizzi C; Servidei T; Pescatori M; Tonali PA; Ricci E; Mirabella M
J Neurochem; 2006 Feb; 96(3):777-89. PubMed ID: 16405511
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers.
Nogalska A; Engel WK; McFerrin J; Kokame K; Komano H; Askanas V
J Neurochem; 2006 Mar; 96(5):1491-9. PubMed ID: 16441512
[TBL] [Abstract][Full Text] [Related]
7. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
8. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
Wójcik S; Engel WK; McFerrin J; Askanas V
Acta Neuropathol; 2005 Aug; 110(2):173-7. PubMed ID: 15983828
[TBL] [Abstract][Full Text] [Related]
9. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
Maurage CA; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux MM; Pellissier JF; Delacourte A
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):624-34. PubMed ID: 15541003
[TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy.
Querfurth HW; Suhara T; Rosen KM; McPhie DL; Fujio Y; Tejada G; Neve RL; Adelman LS; Walsh K
Mol Cell Neurosci; 2001 May; 17(5):793-810. PubMed ID: 11358479
[TBL] [Abstract][Full Text] [Related]
11. Messenger RNA degradation may be inhibited in sporadic inclusion body myositis.
Nakano S; Shinde A; Ito H; Ito H; Kusaka H
Neurology; 2005 Aug; 65(3):420-5. PubMed ID: 16087907
[TBL] [Abstract][Full Text] [Related]
12. Increased aging in primary muscle cultures of sporadic inclusion-body myositis.
Morosetti R; Broccolini A; Sancricca C; Gliubizzi C; Gidaro T; Tonali PA; Ricci E; Mirabella M
Neurobiol Aging; 2010 Jul; 31(7):1205-14. PubMed ID: 18823681
[TBL] [Abstract][Full Text] [Related]
13. Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle.
Broccolini A; Gidaro T; De Cristofaro R; Morosetti R; Gliubizzi C; Ricci E; Tonali PA; Mirabella M
J Neurochem; 2008 May; 105(3):971-81. PubMed ID: 18182043
[TBL] [Abstract][Full Text] [Related]
14. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
Kumamoto T; Ueyama H; Tsumura H; Toyoshima I; Tsuda T
Acta Neuropathol; 2004 Jan; 107(1):59-65. PubMed ID: 14513262
[TBL] [Abstract][Full Text] [Related]
15. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
Askanas V; Engel WK
Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
Askanas V; Engel WK; Nogalska A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
[TBL] [Abstract][Full Text] [Related]
19. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
[TBL] [Abstract][Full Text] [Related]
20. Inclusion body myopathy associated with motor neuron syndrome: three case reports.
Cafforio G; Pistolesi S; D'Avino C; Galluzzi F; Patricelli A; Solito B; Fontanini G; Siciliano G
Clin Neuropathol; 2005; 24(1):36-41. PubMed ID: 15696783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
